Weiling Li

Long-term survival after immunotherapy and targeted therapy without chemotherapy in an elderly patient with HER2-positive gastroesophageal junction cancer: A case report

Xiaoling Zhang, Yunyi Du, Jun Zhao, 2022, Human vaccines & immunotherapeutics.

HER2-targeted advanced metastatic gastric/gastroesophageal junction adenocarcinoma: treatment landscape and future perspectives

Ying Zhang, Xiaoling Zhang, Yunyi Du, 2022, Biomarker Research.

PD-1 inhibitor treatment in a penile cancer patient with MMR/MSI status heterogeneity: A case report

L. Zong, Ying Zhang, Xiaoling Zhang, 2022, Human vaccines & immunotherapeutics.

A difficult-to-diagnose pericardial fistula.

Xiaoling Zhang, Jun Zhao, Liang Zong, 2022, The American journal of the medical sciences.

The clinical application value of phase angle of six parts in nutritional evaluation of tumor patients

Xiaoling Zhang, Jun Zhao, Jialei Zhang, 2022, Supportive Care in Cancer.

Oncological characteristics, treatments and prognostic outcomes in MMR-deficient colorectal cancer

Weiling Li, Yunyi Du, W. Fan, 2024, Biomarker research.

Predictive value of near-term prediction models for severe immune-related adverse events in malignant tumor PD-1 inhibitor therapy

Xiaoling Zhang, Jun Zhao, Weiling Li, 2024, Human vaccines & immunotherapeutics.